117 related articles for article (PubMed ID: 8200112)
1. Investigation of rapamycin transport and uptake across absorptive human intestinal cell monolayers.
Dias VC; Yatscoff RW
Clin Biochem; 1994 Feb; 27(1):31-6. PubMed ID: 8200112
[TBL] [Abstract][Full Text] [Related]
2. An in vitro method for predicting in vivo oral bioavailability of novel immunosuppressive drugs.
Dias VC; Yatscoff RW
Clin Biochem; 1996 Feb; 29(1):43-9. PubMed ID: 8929823
[TBL] [Abstract][Full Text] [Related]
3. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model.
Fryer J; Yatscoff RW; Pascoe EA; Thliveris J
Transplantation; 1993 Feb; 55(2):340-5. PubMed ID: 8434385
[TBL] [Abstract][Full Text] [Related]
4. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
Wu X; Whitfield LR; Stewart BH
Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers.
Wang Y; Cao J; Wang X; Zeng S
Chirality; 2010 Mar; 22(3):361-8. PubMed ID: 19575464
[TBL] [Abstract][Full Text] [Related]
7. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
[TBL] [Abstract][Full Text] [Related]
8. Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival.
Davies CB; Madden RL; Alexander JW; Cofer BR; Fisher RA; Anderson P
Transplantation; 1993 May; 55(5):1107-12. PubMed ID: 8497890
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of L-alpha-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers. Comparison with metabolism in vivo.
Chikhale PJ; Borchardt RT
Drug Metab Dispos; 1994; 22(4):592-600. PubMed ID: 7956735
[TBL] [Abstract][Full Text] [Related]
10. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
11. The transport of lysine across monolayers of human cultured intestinal cells (Caco-2) depends on Na(+)-dependent and Na(+)-independent mechanisms on different plasma membrane domains.
Ferruzza S; Ranaldi G; Di Girolamo M; Sambuy Y
J Nutr; 1995 Oct; 125(10):2577-85. PubMed ID: 7562093
[TBL] [Abstract][Full Text] [Related]
12. Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: an in-vitro study in healthy humans.
Fanigliulo D; Lazzerini PE; Capecchi PL; Ulivieri C; Baldari CT; Laghi-Pasini F
Int Immunopharmacol; 2015 Feb; 24(2):276-284. PubMed ID: 25536542
[TBL] [Abstract][Full Text] [Related]
13. Transport characteristics of ebastine and its metabolites across human intestinal epithelial Caco-2 cell monolayers.
Imamura Y; Shimizu K; Yamashita F; Yamaoka K; Takakura Y; Hashida M
Biol Pharm Bull; 2001 Aug; 24(8):930-4. PubMed ID: 11510488
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interactions between sirolimus and microemulsion cyclosporine when orally administered jointly and 4 hours apart in healthy volunteers.
Zimmerman JJ; Harper D; Getsy J; Jusko WJ
J Clin Pharmacol; 2003 Oct; 43(10):1168-76. PubMed ID: 14517200
[TBL] [Abstract][Full Text] [Related]
15. An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers.
Primavera R; Palumbo P; Celia C; Cinque B; Carata E; Carafa M; Paolino D; Cifone MG; Di Marzio L; Cilurzo F
Eur J Pharm Biopharm; 2018 Jun; 127():432-442. PubMed ID: 29605467
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic monitoring of rapamycin: a new immunosuppressive drug.
Yatscoff RW; LeGatt DF; Kneteman NM
Ther Drug Monit; 1993 Dec; 15(6):478-82. PubMed ID: 8122280
[TBL] [Abstract][Full Text] [Related]
17. Blood distribution of rapamycin.
Yatscoff R; LeGatt D; Keenan R; Chackowsky P
Transplantation; 1993 Nov; 56(5):1202-6. PubMed ID: 8249123
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
Anderson CM; Mendoza ME; Kennedy DJ; Raldua D; Thwaites DT
Br J Pharmacol; 2003 Feb; 138(4):564-73. PubMed ID: 12598410
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
[TBL] [Abstract][Full Text] [Related]
20. Functional Comparison of Human Colonic Carcinoma Cell Lines and Primary Small Intestinal Epithelial Cells for Investigations of Intestinal Drug Permeability and First-Pass Metabolism.
Yamaura Y; Chapron BD; Wang Z; Himmelfarb J; Thummel KE
Drug Metab Dispos; 2016 Mar; 44(3):329-35. PubMed ID: 26700954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]